A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian children

K. A. Bojang, G. Schneider, S. Forck, S. K. Obaro, S. Jaffar, M. Pinder, J. Rowley, B. M. Greenwood

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Chloroquine can no longer be recommended as the first-line treatment for uncomplicated malaria in several parts of Africa because of the increasing prevalence of chloroquine resistance. However, chloroquine was a highly effective treatment for malaria not only because of its ability to kill parasites quickly but also because it is an anti-inflammatory drug. Therefore, we have investigated whether Fansidar® (pyrimethamine/sulfadoxine) plus chloroquine is a more effective treatment for uncomplicated malaria than Fansidar® alone. Four hundred and five Gambian children with uncomplicated Plasmodium falciparum malaria were studied in a randomized controlled trial. Significantly more children treated with Fansidar® alone, compared to those treated with Fansidar® plus chloroquine (19/203 vs. 2/202; P < 0.001), returned to the clinic with persistent symptoms during the first 3 d after treatment. Three children who had received Fansidar® alone had fits, but none of the children treated with Fansidar® plus chloroquine did so. At the day 7 follow-up, the parasite failure rate in the Fansidar® alone group was 3/198 (1.5%), whilst in the Fansidar® plus chloroquine group it was 3/201 (1.5%). At the day 28 follow-up, there was still no significant difference between the parasite failure rate in the Fansidar® alone group (15/150; 10.0%) and the Fansidar® plus chloroquine group (7/141; 5.0%) and the mean packed cell volume (PCV) in the 2 groups was similar. Thus, a combination of Fansidar® plus chloroquine was a more effective symptomatic treatment than Fansidar® given alone, but neither the parasite cure rate nor the PCV was enhanced by use of the combination.

Original languageEnglish (US)
Pages (from-to)73-76
Number of pages4
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene
Volume92
Issue number1
DOIs
StatePublished - Jan 1 1998

Fingerprint

Chloroquine
Malaria
Therapeutics
Parasites
pyrimethamine drug combination fanasil
Erythrocyte Indices
Falciparum Malaria
Cell Size
Anti-Inflammatory Agents
Randomized Controlled Trials

Keywords

  • Chemotherapy
  • Children
  • Chloroquine
  • Fansidar®
  • Malaria
  • Plasmodium falciparum
  • The Gambia

ASJC Scopus subject areas

  • Parasitology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian children. / Bojang, K. A.; Schneider, G.; Forck, S.; Obaro, S. K.; Jaffar, S.; Pinder, M.; Rowley, J.; Greenwood, B. M.

In: Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 92, No. 1, 01.01.1998, p. 73-76.

Research output: Contribution to journalArticle

Bojang, K. A. ; Schneider, G. ; Forck, S. ; Obaro, S. K. ; Jaffar, S. ; Pinder, M. ; Rowley, J. ; Greenwood, B. M. / A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian children. In: Transactions of the Royal Society of Tropical Medicine and Hygiene. 1998 ; Vol. 92, No. 1. pp. 73-76.
@article{6a70b5c76fb4485b9ce784f113803890,
title = "A trial of Fansidar{\circledR} plus chloroquine or Fansidar{\circledR} alone for the treatment of uncomplicated malaria in Gambian children",
abstract = "Chloroquine can no longer be recommended as the first-line treatment for uncomplicated malaria in several parts of Africa because of the increasing prevalence of chloroquine resistance. However, chloroquine was a highly effective treatment for malaria not only because of its ability to kill parasites quickly but also because it is an anti-inflammatory drug. Therefore, we have investigated whether Fansidar{\circledR} (pyrimethamine/sulfadoxine) plus chloroquine is a more effective treatment for uncomplicated malaria than Fansidar{\circledR} alone. Four hundred and five Gambian children with uncomplicated Plasmodium falciparum malaria were studied in a randomized controlled trial. Significantly more children treated with Fansidar{\circledR} alone, compared to those treated with Fansidar{\circledR} plus chloroquine (19/203 vs. 2/202; P < 0.001), returned to the clinic with persistent symptoms during the first 3 d after treatment. Three children who had received Fansidar{\circledR} alone had fits, but none of the children treated with Fansidar{\circledR} plus chloroquine did so. At the day 7 follow-up, the parasite failure rate in the Fansidar{\circledR} alone group was 3/198 (1.5{\%}), whilst in the Fansidar{\circledR} plus chloroquine group it was 3/201 (1.5{\%}). At the day 28 follow-up, there was still no significant difference between the parasite failure rate in the Fansidar{\circledR} alone group (15/150; 10.0{\%}) and the Fansidar{\circledR} plus chloroquine group (7/141; 5.0{\%}) and the mean packed cell volume (PCV) in the 2 groups was similar. Thus, a combination of Fansidar{\circledR} plus chloroquine was a more effective symptomatic treatment than Fansidar{\circledR} given alone, but neither the parasite cure rate nor the PCV was enhanced by use of the combination.",
keywords = "Chemotherapy, Children, Chloroquine, Fansidar{\circledR}, Malaria, Plasmodium falciparum, The Gambia",
author = "Bojang, {K. A.} and G. Schneider and S. Forck and Obaro, {S. K.} and S. Jaffar and M. Pinder and J. Rowley and Greenwood, {B. M.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0035-9203(98)90962-2",
language = "English (US)",
volume = "92",
pages = "73--76",
journal = "Transactions of the Royal Society of Tropical Medicine and Hygiene",
issn = "0035-9203",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian children

AU - Bojang, K. A.

AU - Schneider, G.

AU - Forck, S.

AU - Obaro, S. K.

AU - Jaffar, S.

AU - Pinder, M.

AU - Rowley, J.

AU - Greenwood, B. M.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Chloroquine can no longer be recommended as the first-line treatment for uncomplicated malaria in several parts of Africa because of the increasing prevalence of chloroquine resistance. However, chloroquine was a highly effective treatment for malaria not only because of its ability to kill parasites quickly but also because it is an anti-inflammatory drug. Therefore, we have investigated whether Fansidar® (pyrimethamine/sulfadoxine) plus chloroquine is a more effective treatment for uncomplicated malaria than Fansidar® alone. Four hundred and five Gambian children with uncomplicated Plasmodium falciparum malaria were studied in a randomized controlled trial. Significantly more children treated with Fansidar® alone, compared to those treated with Fansidar® plus chloroquine (19/203 vs. 2/202; P < 0.001), returned to the clinic with persistent symptoms during the first 3 d after treatment. Three children who had received Fansidar® alone had fits, but none of the children treated with Fansidar® plus chloroquine did so. At the day 7 follow-up, the parasite failure rate in the Fansidar® alone group was 3/198 (1.5%), whilst in the Fansidar® plus chloroquine group it was 3/201 (1.5%). At the day 28 follow-up, there was still no significant difference between the parasite failure rate in the Fansidar® alone group (15/150; 10.0%) and the Fansidar® plus chloroquine group (7/141; 5.0%) and the mean packed cell volume (PCV) in the 2 groups was similar. Thus, a combination of Fansidar® plus chloroquine was a more effective symptomatic treatment than Fansidar® given alone, but neither the parasite cure rate nor the PCV was enhanced by use of the combination.

AB - Chloroquine can no longer be recommended as the first-line treatment for uncomplicated malaria in several parts of Africa because of the increasing prevalence of chloroquine resistance. However, chloroquine was a highly effective treatment for malaria not only because of its ability to kill parasites quickly but also because it is an anti-inflammatory drug. Therefore, we have investigated whether Fansidar® (pyrimethamine/sulfadoxine) plus chloroquine is a more effective treatment for uncomplicated malaria than Fansidar® alone. Four hundred and five Gambian children with uncomplicated Plasmodium falciparum malaria were studied in a randomized controlled trial. Significantly more children treated with Fansidar® alone, compared to those treated with Fansidar® plus chloroquine (19/203 vs. 2/202; P < 0.001), returned to the clinic with persistent symptoms during the first 3 d after treatment. Three children who had received Fansidar® alone had fits, but none of the children treated with Fansidar® plus chloroquine did so. At the day 7 follow-up, the parasite failure rate in the Fansidar® alone group was 3/198 (1.5%), whilst in the Fansidar® plus chloroquine group it was 3/201 (1.5%). At the day 28 follow-up, there was still no significant difference between the parasite failure rate in the Fansidar® alone group (15/150; 10.0%) and the Fansidar® plus chloroquine group (7/141; 5.0%) and the mean packed cell volume (PCV) in the 2 groups was similar. Thus, a combination of Fansidar® plus chloroquine was a more effective symptomatic treatment than Fansidar® given alone, but neither the parasite cure rate nor the PCV was enhanced by use of the combination.

KW - Chemotherapy

KW - Children

KW - Chloroquine

KW - Fansidar®

KW - Malaria

KW - Plasmodium falciparum

KW - The Gambia

UR - http://www.scopus.com/inward/record.url?scp=0031595850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031595850&partnerID=8YFLogxK

U2 - 10.1016/S0035-9203(98)90962-2

DO - 10.1016/S0035-9203(98)90962-2

M3 - Article

C2 - 9692160

AN - SCOPUS:0031595850

VL - 92

SP - 73

EP - 76

JO - Transactions of the Royal Society of Tropical Medicine and Hygiene

JF - Transactions of the Royal Society of Tropical Medicine and Hygiene

SN - 0035-9203

IS - 1

ER -